Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET February 18, 2009 to Discuss Fourth Quarter 2008 Results

Thursday, February 12, 2009 General News
Email Print This Page Comment bookmark
Font : A-A+

WALTHAM, Mass., Feb. 11 Inverness Medical Innovations, Inc. (NYSE: IMA), a global leader in rapid point-of-care diagnostic products, today announced that it will release its fourth quarter 2008 earnings on Wednesday, February 18, 2009. The Company will also host a conference call beginning at 10:00 a.m. (Eastern Time) on that date to discuss these results and other corporate matters. During the conference call the Company may discuss and answer questions concerning business and financial developments and trends. The Company's responses to questions, as well as other matters discussed during the conference call, may contain or constitute information that has not been disclosed previously.



The conference call may be accessed by dialing 706-679-1656 (domestic and international), an access code is not required, or via a link on the Inverness website at www.invernessmedical.com. It is also available via link at https://event.meetingstream.com/r.htm?e=134985&s=1&k=91C3084D8CBF362549FF6D6A8D9F0BDC using Real Player or Windows Media. An on-demand web cast of the call will be available at the Inverness website (www.invernessmedical.com/News.cfm) two hours after the end of the call and will be accessible for 30 days.



By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.



For additional information on Inverness Medical Innovations, please visit www.invernessmedical.com.



SOURCE Inverness Medical Innovations, Inc.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store